VALUECARE
LIVE

Serial Number

99274894

Owner

Cabinet Health P.B.C.

Attorney

Francis Gilbert G Gleason Jr.

Filing Date

Jul 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VALUECARE Trademark

Serial Number: 99274894

VALUECARE is a trademark filed by Cabinet Health P.B.C. on July 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Cabinet Health P.B.C. (5 trademarks)

33 Nassau Ave
Brooklyn, NY 11222

Entity Type: 58

Trademark Details

Filing Date

July 9, 2025

Registration Date

Not Registered

Published for Opposition

December 23, 2025

Goods & Services

Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Analgesic and muscle relaxant pharmaceutical preparations; Herbal supplements; Natural herbal supplements; Liquid herbal supplements; Nutritional supplements in the form of capsules, tablets, powder, gummy and liquid; Enzyme dietary supplements

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 17, 2026 NOAM
ASSIGNED TO EXAMINER
Jan 24, 2026 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 27, 2025 CNSA
ASSIGNED TO EXAMINER
Nov 27, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 9, 2025 MAFR
NEW APPLICATION ENTERED
Jul 9, 2025 NWAP